CompletedEUCTR 2006-004783-31
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In HungarySchizophreniaHistorical research record
- Countries
- Hungary, Latvia
- Sponsor
- AstraZeneca AB
CompletedEUCTR 2008-001673-15
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In EstoniaAnxietyHistorical research record
- Countries
- France, Estonia, Finland, + 1 other
- Sponsor
- H. Lundbeck A/S
CompletedEUCTR 2013-000212-22
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In PolandSchizophreniaHistorical research record
- Countries
- United Kingdom, Poland, Romania
- Sponsor
- GW Research Ltd
TerminatedEUCTR 2005-005499-34
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GreeceSchizophreniaHistorical research record
- Countries
- Greece
- Sponsor
- H. Lundbeck A/S
CompletedEUCTR 2017-001941-28
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicSchizophreniaHistorical research record
- Countries
- Czechia, Germany, Italy, + 2 others
- Sponsor
- Janssen-Cilag International NV
CompletedEUCTR 2016-003990-17
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaDepressionHistorical research record
- Countries
- Bulgaria, Germany, Hungary, + 2 others
- Sponsor
- Janssen-Cilag International NV
CompletedACTRN12622000713796
Official study titleA Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single, Ascending, Subcutaneous Doses of FT-104 HCl In Healthy Volunteers
Safety, Tolerability, and Pharmacokinetics of Subcutaneous FT-104 HCl (SAIL-101)
This study has finished and is no longer accepting participants.
In AdelaideDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Field Trip Psychedelics Inc
CompletedACTRN12606000272594
Official study titleA double-blinded, placebo-controlled trial of modafinil for amphetamine withdrawal in adults who are currently dependent on amphetamines
This study has finished and is no longer accepting participants.
Location not clearly listedMental healthInterventional studyAges 18+
- Countries
- Sponsor
- Government Department of Health and Aging.
CompletedNCT01094249
Official study titleAn Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Paliperidone Extended-Release on the Steady-State Pharmacokinetics of Valproic Acid in Clinically Stable Subjects With Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including KissimmeeBipolarity, SchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT01060228
Official study titleAn Open-Label, Drug-Drug Interaction Study Between Steady-State Valproic Acid and Single-Dose Paliperidone Extended-Release in Healthy Men
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–55
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
TerminatedNCT01802515
Official study titleAtomoxetine Treatment for Opioid Maintained Cocaine Users
This study ended early.
In West HavenAddictionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT03451344
Official study titleA Community-based Addiction Rehabilitation Electronic System to Improve Recovery Outcomes in Patients With Drug Use Disorder: Protocol for a Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In ShanghaiAddictionInterventional studyAges 20–50
- Countries
- China
- Sponsor
- Shanghai Mental Health Center